Medication Administration Curriculum INSTRUCTOR’S MANUAL

The recommendations in this publication do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate. Copyright © 2013 American Academy of Pediatrics. All Rights Reserved. The American Academy of Pediatrics does not review or endorse any modifications made to this document and in no event shall the AAP be liable for such changes.

Group Activity: Receiving Medication, Scenario 2

Maria is 3-years-old and has eczema. She needs hydrocortisone cream applied to her arms at noon time. This is an OTC medication with a brand name of Aveeno®. Aveeno also makes other non-medicated skin moisturizers as well, but the medication that is being requested is an OTC hydrocortisone cream. Maria has had this medication before.

• Switch roles from Scenario 1: Nick.

• Materials

– Labeled “Aveeno®” in containers

– Medication Packet with completed Authorization to Give Medicine and Receiving Medication with child’s name on the top that participants will complete

– Completed Universal Child Health Record

– Storage box to place medication (assume that it is locked)

• Conclude the activity with the instructor posing “What if” questions like:

– “What if the label with Maria’s name blocked the instructions?”

– “What if the permission form was incomplete?”

• Answer: The medication should not be accepted until the problem is fixed.

Instructor Note:

For activity, make 2 demonstration models:

• Cream with instructions blocked by Maria’s name

• Incomplete Authorization to Give Medicine form

Medication Administration Curriculum INSTRUCTOR’S MANUAL

Adapted from © 2006 UNC-CH/MCH and NC DHHS/DCD

Dru

g Fa

cts

Dru

g Fa

cts

(con

tinue

d)

Act

ive

ingr

edie

nt

P

urpo

seH

ydro

corti

sone

1%

……

……

……

……

……

……

……

……

...…

…...

Ant

i-itc

h

War

ning

s (c

ontin

ued)

Kee

p ou

t of r

each

of c

hild

ren.

If s

wal

low

ed, g

et m

edic

al h

elp

or c

onta

ct a

P

oiso

n C

ontro

l Cen

ter r

ight

aw

ay.

Dir

ectio

ns*a

dults

and

chi

ldre

n 2

year

s an

d ol

der:

appl

y to

affe

cted

are

a no

t mor

e th

an 3

-4 ti

mes

dai

ly*c

hild

ren

unde

r 2 y

ears

of a

ge: d

o no

t use

, ask

a d

octo

r

Inac

tive

ingr

edie

nts

Alo

e ba

rbad

ensi

s le

af ju

ice,

Ave

na s

ativ

a (o

at) k

erne

l flo

ur, b

eesw

ax,

cety

l alc

ohol

, citr

ic a

cid,

gly

cery

l ste

arat

e, is

opro

pyl m

yris

tate

, m

ethy

lpar

aben

, PE

G-4

0 st

eara

te, p

olys

orba

te 6

0, p

ropy

lene

gly

col,

prop

ylpa

rabe

n, s

odiu

m c

itrat

e, s

orbi

c ac

id, s

orbi

tan

stea

rate

, ste

aryl

al

coho

l, to

coph

eryl

ace

tate

, wat

er

War

ning

sFo

r ex

tern

al u

se o

nly

Oth

er in

form

atio

nS

tore

at r

oom

tem

pera

ture

. Pro

tect

from

free

zing

and

exc

essi

ve h

eat.

Do

not u

se *

in th

e ey

es

*fo

r the

trea

tmen

t of d

iape

r ras

h

Whe

n us

ing

this

pro

duct

do

not b

egin

the

use

of a

ny o

ther

hyd

roco

rtiso

ne p

rodu

ctS

top

use

and

ask

a do

ctor

if

*sym

ptom

s la

st fo

r mor

e th

an 7

day

s *

the

cond

ition

get

s w

orse

*sy

mpt

oms

clea

r up

and

com

e ba

ck in

a fe

w d

ays

Exp

10/

200X

Que

stio

ns?

1-87

7-29

8-25

25

Eff

ectiv

e R

elie

f of I

tchi

ng fr

omIn

flam

mat

ion

and

Ras

hes

due

to:

Ecz

ema

*Pso

riasi

s *S

ebor

rhei

c D

erm

atiti

sP

oiso

n Iv

y *O

ak *

Sum

ac *

Inse

ct B

ites

Det

erge

nts

*Soa

ps *

Cos

met

ics

*Jew

elry

Ave

eno

1% H

YD

RO

CO

RTI

SO

NE

AN

TI-IT

CH

CR

EA

M

Use

s*p

rovi

des

tem

pora

ry re

lief o

f the

itch

ing

asso

ciat

ed w

ith m

inor

ski

n irr

itatio

ns,

infla

mm

atio

n, a

nd ra

shes

from

:*e

czem

a *p

soria

sis

*inse

ct b

ites

*seb

orrh

eic

derm

atiti

s *s

oaps

*po

ison

ivy

*poi

son

oak

*poi

son

sum

ac *

jew

elry

*co

smet

ics

*det

erge

nts

*oth

er u

ses

of th

is p

rodu

ct s

houl

d be

onl

y un

der t

he a

dvic

e an

d su

perv

isio

n of

a

doct

or

Group Activity: Receiving Medication, Scenario 2

Group Activity: Receiving Medication, Scenario 2

Group Activity: Receiving Medication, Scenario 2

Group Activity: Receiving Medication, Scenario 2

Group Activity: Receiving Medication, Scenario 2